Atlas Trials

Locally Recurrent

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Recurrent

RecordFirmDate
A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer (NCT01268150)Eisai Inc.2011-02-01

Track Locally Recurrent automatically

Every clearance here is in the API, with alerts when new ones post.